AzTrials
AzTrials

Intensive Care Unit SyndromeNCT06075121

Enteral Nutrition and Abdominal Massage

A study testing Abdominal massage in people with Intensive Care Unit Syndrome, run by Amasya University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will be conducted to determine the effect of abominal massage on feeding intolerance and blood sugar levels in intensive care patients who are continuously feeding enterally and have diabetes. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Intensive Care Unit Syndrome
What is being tested?
Abdominal massage
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
1 siteTurkey (Türkiye)
Study dates
12 Jun 2023to 22 Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • The age of 18 years and over
  • Diagnosed with diabetes mellitus
  • Having just started continuous enteral feeding via nasogastric tube
  • Glasgow coma scale >3
  • Patients who do not have a wound in the abdominal area
  • Patients without current diarrhea, constipation, vomiting, abdominal distension
  • Patients who gave their consent to participate in the research

Who cannot join

  • Patients who had started enteral feeding before starting the study
  • Patients who received radiotherapy to the abdominal area
  • Abdominal surgery within the last three months
  • Patients with ileus
  • Patients using medications that affect gastrointestinal motility

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Amasya U

    Amasya

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Abdominal Massage on Feeding Intolerance and Blood Sugar Level in Intensive Care Patients with Diabetes and Continuous Enteral Feeding

This study will be conducted to determine the effect of abominal massage on feeding intolerance and blood sugar levels in intensive care patients who are continuously feeding enterally and have diabetes.

Read the detailed description

Introduction: Many multiple and challenging problems are encountered in patients followed in intensive care. The most important of these symptoms is nutritional problems. One of the most commonly used methods in the treatment of nutritional problems is enteral nutrition. In addition to its beneficial results, gastrointestinal problems such as abdominal distension, constipation, diarrhea, nausea and vomiting may be encountered in enteral fed individuals in intensive care units. Although different methods are used in the management of complications that may develop in enterally fed patients, abdominal massage, which is one of the non-invasive nursing practices, has been shown to reduce feeding intolerance and balance blood glucose levels.

Purpose: This study will be conducted to determine the effect of abominal massage applied to intensive care patients who are continuously fed enterally and have diabetes, on feeding intolerance and blood sugar levels.

Method: This study will be conducted using a randomized controlled research design. The research sample will consist of 64 patients hospitalized in the intensive care units of a state hospital in Merzifon and who meet the inclusion criteria. Research data will be collected using the clinical status information form, patient parameters monitoring form, and Bristol stool scale. Patients in the massage group will receive an abdominal massage twice a day for 5 days, between 10.00 in the morning and 22.00 in the evening. For the control group, routine treatment and care practices in the hospital will continue without any additional intervention for these 5 days, and the same data will be evaluated at the same time.

Conclusion: It is thought that abdominal massage applied to intensive care patients with diabetes who are continuously fed enterally will reduce feeding intolerance and affect blood sugar levels.

Being tested
Abdominal massage
Keywords
massage

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Abdominal massageOther

    Patients in the massage group will receive an abdominal massage twice a day for 5 days, between 10.00 in the morning and 22.00 in the evening. Enteral nutrition will be interrupted twice a day for 5 days, between 09.30-10.00 in the morning and 21.30-22.00 in the evening, and patients will receive an abdominal massage for 15 minutes.

Study groups in NCT06075121
Study groupRoleWhat they receive
Abdominal massage groupExperimentalPatients in the massage group will receive an abdominal massage twice a day for 5 days, between 10.00 in the morning and 22.00 in the evening for 15 minutes.
Receives: Other: Abdominal massage
Control groupNo interventionRoutine treatment and care practices in the hospital will continue for 5 days without any additional intervention and the same data will be evaluated at the same time.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gastric residual volume

    Gastric residual volume will be done every four hours. GRV measurement will be made 30 minutes after stopping feeding.

    Measured: 5 days

  2. Abdominal Distension

    Abdominal Distension be evaluated 30 minutes after stopping feeding. Abdominal distention control will be done using the palpation method.

    Measured: 5 days

  3. Bristol stool scale scale

    This scale is designed to classify an individual's bowel movements into seven separate categories of stool. According to the "Bristol Stool Consistency Scale", Type 1 and Type 2 indicate constipation, Type 3 and Type 4 indicate normal defecation, and Type 5, Type 6 and Type 7 indicate diarrhea.

    Measured: 5 days

  4. Blood sugar

    Blood glucose levels will be checked four times a day at 10:00-14:00-18:00 and 22:00.

    Measured: 5 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Oct 2023
  2. Study start12 Jun 2023
  3. Primary completion22 Jun 2024
  4. Study completion22 Jun 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
64 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06075121
Sponsor's protocol ID
AmasyaU-EY-208
Status last verified
Oct 2023
First submitted
27 Sep 2023
Last updated
20 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Abdominal massage in people with Intensive Care Unit Syndrome, run by Amasya University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gastric residual volume (time frame: 5 days). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in